Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine vs ropivacaine for interscalene brachial plexus block after shoulder arthroscopy
ChiCTR2500112232Phase 4Recruiting
- Sponsor
- Liaoning Provincial People's Hospital
- Start
- Nov 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial in Rotator cuff deficiency (RCD) comparing Liposomal bupivacaine interscalene block with Ropivacaine interscalene block (2 arms). Primary endpoint: Patient NRS pain score. Started Nov 2025; status: recruiting.
02
Drugs
liposomal bupivacaineropivacaine
03
Conditions
Rotator cuff deficiency (RCD)
Beyond the preview
Go deeper on ChiCTR2500112232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500112232.